Dr. Jiang’s lab has significant expertise in developing multifunctional nanostructures to modulate cellular responses. The lab’s recent work focused on developing nanomaterial-based platforms to help engage the immune system with cancer cells in order to generate antitumor responses, which includes the development of multivalent bi-specific nanobioconjugate systems to promote tumor cell phagocytosis as well as immune nanomedicine that stimulate the activation of innate immune-sensing pathways in professional antigen-presenting cells.